Sofinnova steps up
Why Sofinnova Ventures upped the size of its tenth fund
With fewer crossover investors participating in its private biotech financings, Sofinnova Ventures has raised a new $650 million fund that will allow it to invest more capital per company to see them through key milestones.
Sofinnova Venture Partners Fund X closed on Oct. 17. It is the firm’s third dedicated life sciences fund